secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001140361-24-001200
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano prelim Q4 rev $10.4-10.7M (+27-30% YoY); OGM base 326 (+36%)
--------------------------------------------------------------------

- Prelim Q4 2023 rev $10.4-10.7M vs $8.2M Q4 2022; FY rev $35.8-36.1M (+29-30%).
- OGM installed base 326 as of year-end 2023, up 36% from 240 in 2022.
- Q4 flowcell sales 7,980, up 67% from 4,781 in Q4 2022.
- Cash, equivalents & securities ~$102.8M at Dec 31, 2023; $36.1M restricted.
- Raised net $11.0M from ATM in Nov-Dec 2023 and $2.9M additional in Jan 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124001200/0001140361-24-001200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124001200/ef20018237_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-001200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer